Cargando…

A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma

Zinc-finger protein 304 (ZNF304) plays a critical role in silencing genes through transcription, regulating cell survival, proliferation, apoptosis, and differentiation during development. However, the roles of transcription factor ZNF304 and its clinical significance in clear cell renal carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Li-Xin, Zeng, Bo-Wen, Zhu, Meng, Zhao, An-Ning, Shi, Bei, Zhang, Hong, Wang, Dan-Dan, Gu, Jun-Fei, Yang, Zhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529286/
https://www.ncbi.nlm.nih.gov/pubmed/34692488
http://dx.doi.org/10.3389/fonc.2021.710525
_version_ 1784586438380093440
author Ren, Li-Xin
Zeng, Bo-Wen
Zhu, Meng
Zhao, An-Ning
Shi, Bei
Zhang, Hong
Wang, Dan-Dan
Gu, Jun-Fei
Yang, Zhan
author_facet Ren, Li-Xin
Zeng, Bo-Wen
Zhu, Meng
Zhao, An-Ning
Shi, Bei
Zhang, Hong
Wang, Dan-Dan
Gu, Jun-Fei
Yang, Zhan
author_sort Ren, Li-Xin
collection PubMed
description Zinc-finger protein 304 (ZNF304) plays a critical role in silencing genes through transcription, regulating cell survival, proliferation, apoptosis, and differentiation during development. However, the roles of transcription factor ZNF304 and its clinical significance in clear cell renal carcinoma (ccRCC) remain unclear. In this study, we found that the expression of ZNF304 was downregulated in ccRCC tissues. Lower levels of ZNF304 were correlated with poor survival. Downregulation of ZNF304 promoted ccRCC cell growth in vitro, whereas overexpression of ZNF304 inhibited growth. Our results indicated that miR-183-5p/FOXO4 mediated ZNF304 regulation of cell growth. Interestingly, we revealed that ZNF304 promoted FOXO4 expression in ccRCC cells. Mechanistically, ZNF304 binds to miR-183 promoter and inhibits miR-183-5p transcription. Furthermore, the expression of miR-183-5p wes increased in ccRCC tissues, and the upregulation of miR-183-5p was related to the poor prognosis of ccRCC patients. miR-183-5p upregulation repressed the expression of FOXO4 and promoted ccRCC progression. These results demonstrated that ZNF304/miR-183-5p/FOXO4 axis played essential role in promoting ccRCC progression, which suggests that disruption of this axis may be a potential therapeutic target in ccRCC.
format Online
Article
Text
id pubmed-8529286
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85292862021-10-22 A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma Ren, Li-Xin Zeng, Bo-Wen Zhu, Meng Zhao, An-Ning Shi, Bei Zhang, Hong Wang, Dan-Dan Gu, Jun-Fei Yang, Zhan Front Oncol Oncology Zinc-finger protein 304 (ZNF304) plays a critical role in silencing genes through transcription, regulating cell survival, proliferation, apoptosis, and differentiation during development. However, the roles of transcription factor ZNF304 and its clinical significance in clear cell renal carcinoma (ccRCC) remain unclear. In this study, we found that the expression of ZNF304 was downregulated in ccRCC tissues. Lower levels of ZNF304 were correlated with poor survival. Downregulation of ZNF304 promoted ccRCC cell growth in vitro, whereas overexpression of ZNF304 inhibited growth. Our results indicated that miR-183-5p/FOXO4 mediated ZNF304 regulation of cell growth. Interestingly, we revealed that ZNF304 promoted FOXO4 expression in ccRCC cells. Mechanistically, ZNF304 binds to miR-183 promoter and inhibits miR-183-5p transcription. Furthermore, the expression of miR-183-5p wes increased in ccRCC tissues, and the upregulation of miR-183-5p was related to the poor prognosis of ccRCC patients. miR-183-5p upregulation repressed the expression of FOXO4 and promoted ccRCC progression. These results demonstrated that ZNF304/miR-183-5p/FOXO4 axis played essential role in promoting ccRCC progression, which suggests that disruption of this axis may be a potential therapeutic target in ccRCC. Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529286/ /pubmed/34692488 http://dx.doi.org/10.3389/fonc.2021.710525 Text en Copyright © 2021 Ren, Zeng, Zhu, Zhao, Shi, Zhang, Wang, Gu and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ren, Li-Xin
Zeng, Bo-Wen
Zhu, Meng
Zhao, An-Ning
Shi, Bei
Zhang, Hong
Wang, Dan-Dan
Gu, Jun-Fei
Yang, Zhan
A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma
title A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma
title_full A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma
title_fullStr A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma
title_full_unstemmed A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma
title_short A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma
title_sort novel znf304/mir-183-5p/foxo4 pathway regulates cell proliferation in clear cell renal carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529286/
https://www.ncbi.nlm.nih.gov/pubmed/34692488
http://dx.doi.org/10.3389/fonc.2021.710525
work_keys_str_mv AT renlixin anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT zengbowen anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT zhumeng anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT zhaoanning anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT shibei anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT zhanghong anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT wangdandan anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT gujunfei anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT yangzhan anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT renlixin novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT zengbowen novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT zhumeng novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT zhaoanning novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT shibei novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT zhanghong novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT wangdandan novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT gujunfei novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma
AT yangzhan novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma